Else Research Development from 2010 to 2026

BABY Stock   0.10  0.01  9.09%   
Else Nutrition Research Development yearly trend continues to be very stable with very little volatility. Research Development is likely to drop to about 1.3 M. During the period from 2010 to 2026, Else Nutrition Research Development quarterly data regression pattern had sample variance of 834.2 B and median of  261,000. View All Fundamentals
 
Research Development  
First Reported
2015-09-30
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
315.7 K
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Else Nutrition financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Else Nutrition's main balance sheet or income statement drivers, such as Selling General Administrative of 6.8 M, Other Operating Expenses of 27.4 M or Total Operating Expenses of 5.6 M, as well as many indicators such as Price To Sales Ratio of 0.34, Dividend Yield of 0.0 or PTB Ratio of 1.23. Else financial statements analysis is a perfect complement when working with Else Nutrition Valuation or Volatility modules.
  
This module can also supplement various Else Nutrition Technical models . Check out the analysis of Else Nutrition Correlation against competitors.

Latest Else Nutrition's Research Development Growth Pattern

Below is the plot of the Research Development of Else Nutrition Holdings over the last few years. It is Else Nutrition's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Else Nutrition's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Else Research Development Regression Statistics

Arithmetic Mean769,765
Geometric Mean74,932
Coefficient Of Variation118.65
Mean Deviation782,146
Median261,000
Standard Deviation913,326
Sample Variance834.2B
Range2.6M
R-Value0.78
Mean Square Error347B
R-Squared0.61
Significance0.0002
Slope141,264
Total Sum of Squares13.3T

Else Research Development History

20261.3 M
20251.3 M
20241.2 M
20232.6 M
20222.6 M
2021M
20201.1 M

About Else Nutrition Financial Statements

Else Nutrition investors utilize fundamental indicators, such as Research Development, to predict how Else Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development1.3 M1.3 M

Other Information on Investing in Else Stock

Else Nutrition financial ratios help investors to determine whether Else Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Else with respect to the benefits of owning Else Nutrition security.